<DOC>
	<DOCNO>NCT00587938</DOCNO>
	<brief_summary>Measurement brain natriuretic peptide ( BNP ) dyspneic patient increase diagnostic accuracy congestive heart failure ( CHF ) . Limited information available regard economic outcome attributable BNP assay . The aim study assess economic impact BNP assay elderly dyspneic patient present emergency department ( ED ) .</brief_summary>
	<brief_title>BNP Measurement Reduces Resource Utilization Patients With CHF Admitted Thorough ED</brief_title>
	<detailed_description>Dyspneic patient 65 year enrol randomize , control trial ; hemodynamically unstable patient exclude . BNP ( Biosite assay ) level measure prior physician assessment randomization 1:1 ratio either BNP 1 ) level report 2 ) level report . ED physician make triage decision guide clinical judgment nomogram aid interpretation BNP level . Primary outcome mean total hospital cost per subject . Secondary outcome include admission rate , service assignment , discharge diagnosis length stay . Differences group compare t-test bootstrap . Costs reflect 2005 constant dollar .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Dyspneic patient 65 year old present ED chief complaint shortness breath . hemodynamically unstability</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>congestive heart failure</keyword>
	<keyword>Brain naturietic peptide</keyword>
	<keyword>hospital utilization cost</keyword>
</DOC>